BlackRock
PGEN icon

BlackRock’s Precigen PGEN Stock Holding History

BlackRock’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97.7M Buy
17,146,921
+1,923,730
+13% +$8.32M ﹤0.01% 2240
2026
Q1 		$58.9M Buy
15,223,191
+128,832
+0.9% +$529K ﹤0.01% 2408
2025
Q4 		$63.1M Buy
15,094,359
+2,944,404
+24% +$11.4M ﹤0.01% 2374
2025
Q3 		$40M Buy
12,149,955
+1,004,454
+9% +$2.84M ﹤0.01% 2643
2025
Q2 		$15.8M Buy
11,145,501
+393,286
+4% +$559K ﹤0.01% 3159
2025
Q1 		$16M Buy
10,752,215
+375,572
+4% +$591K ﹤0.01% 3064
2024
Q4 		$11.6M Buy
10,376,643
+8,146
+0.1% +$6.95K ﹤0.01% 3353
2024
Q3 		$9.82M Buy
10,368,497
+121,439
+1% +$153K ﹤0.01% 3418
2024
Q2 		$16.2M Sell
10,247,058
-116,070
-1% -$169K ﹤0.01% 3105
2024
Q1 		$15M Sell
10,363,128
-756,992
-7% -$1.09M ﹤0.01% 3143
2023
Q4 		$14.9M Buy
11,120,120
+663,862
+6% +$780K ﹤0.01% 3177
2023
Q3 		$14.8M Buy
10,456,258
+89,614
+0.9% +$127K ﹤0.01% 3106
2023
Q2 		$11.9M Buy
10,366,644
+784,760
+8% +$926K ﹤0.01% 3336
2023
Q1 		$10.2M Buy
9,581,884
+1,409,360
+17% +$2.03M ﹤0.01% 3315
2022
Q4 		$12.4M Buy
8,172,524
+336,975
+4% +$580K ﹤0.01% 3290
2022
Q3 		$16.6M Buy
7,835,549
+97,314
+1% +$205K ﹤0.01% 3136
2022
Q2 		$10.4M Buy
7,738,235
+512,594
+7% +$760K ﹤0.01% 3490
2022
Q1 		$15.2M Buy
7,225,641
+46,196
+0.6% +$112K ﹤0.01% 3344
2021
Q4 		$26.6M Buy
7,179,445
+7,134
+0.1% +$30.7K ﹤0.01% 3099
2021
Q3 		$35.8M Sell
7,172,311
-23,629
-0.3% -$136K ﹤0.01% 2884
2021
Q2 		$46.9M Sell
7,195,940
-179,685
-2% -$1.26M ﹤0.01% 2744
2021
Q1 		$50.8M Buy
7,375,625
+726,353
+11% +$6.14M ﹤0.01% 2598
2020
Q4 		$67.8M Sell
6,649,272
-329,833
-5% -$2.14M ﹤0.01% 2290
2020
Q3 		$24.4M Sell
6,979,105
-232,882
-3% -$1.11M ﹤0.01% 2750
2020
Q2 		$36M Buy
7,211,987
+405,708
+6% +$1.38M ﹤0.01% 2443
2020
Q1 		$23.1M Sell
6,806,279
-135,244
-2% -$584K ﹤0.01% 2531
2019
Q4 		$38M Sell
6,941,523
-456,879
-6% -$2.57M ﹤0.01% 2528
2019
Q3 		$42.3M Buy
7,398,402
+41,221
+0.6% +$280K ﹤0.01% 2395
2019
Q2 		$56.4M Buy
7,357,181
+932,636
+15% +$5.02M ﹤0.01% 2254
2019
Q1 		$33.8M Sell
6,424,545
-166,118
-3% -$1.15M ﹤0.01% 2504
2018
Q4 		$43.1M Buy
6,590,663
+1,572,900
+31% +$17.6M ﹤0.01% 2326
2018
Q3 		$86.4M Buy
5,017,763
+370,209
+8% +$5.51M ﹤0.01% 2056
2018
Q2 		$64.8M Buy
4,647,554
+2,019,142
+77% +$34.1M ﹤0.01% 2212
2018
Q1 		$40.3M Buy
2,628,412
+65,301
+3% +$934K ﹤0.01% 2395
2017
Q4 		$29.5M Buy
2,563,111
+142,915
+6% +$2.13M ﹤0.01% 2579
2017
Q3 		$46M Buy
2,420,196
+61,140
+3% +$1.26M ﹤0.01% 2344
2017
Q2 		$56.8M Buy
2,359,056
+20,277
+0.9% +$445K ﹤0.01% 2161
2017
Q1 		$46.4M Buy
2,338,779
+2,329,219
+24,364% +$52M ﹤0.01% 2270
2016
Q4 		$230K Sell
9,560
-515
-5% -$14.3K ﹤0.01% 2055
2016
Q3 		$280K Buy
10,075
+3,248
+48% +$85.9K ﹤0.01% 1981
2016
Q2 		$166K Buy
6,827
+995
+17% +$28.2K ﹤0.01% 2212
2016
Q1 		$195K Buy
5,832
+4,447
+321% +$140K ﹤0.01% 1743
2015
Q4 		$42K Sell
1,385
-488
-26% -$16.4K ﹤0.01% 2160
2015
Q3 		$59K Buy
1,873
+635
+51% +$31K ﹤0.01% 1843
2015
Q2 		$60K Buy
1,238
+396
+47% +$16.7K ﹤0.01% 1922
2015
Q1 		$37K Hold
842
– – ﹤0.01% 2079
2014
Q4 		$22K Hold
842
– – ﹤0.01% 2325
2014
Q3 		$15K Hold
842
– – ﹤0.01% 2499
2014
Q2 		$20K Buy
842
+555
+193% +$11.3K ﹤0.01% 2381
2014
Q1 		$7K Buy
+287
New +$7.95K ﹤0.01% 2936

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return

BlackRock's PGEN Position: Q2 2026 in Review

BlackRock increased its Precigen (PGEN) stake by 13% in Q2 2026, buying an estimated $8.32M and bringing the position to 17,146,921 shares worth $97.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2240.

BlackRock first reported a position in PGEN in Q1 2014 and has held it in 50 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • BlackRock held 17,146,921 shares of Precigen worth $97.7M as of Q2 2026.
  • BlackRock bought 1,923,730 Precigen shares in Q2 2026, an estimated $8.32M.
  • Precigen made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2240 holding.
  • BlackRock first reported a position in Precigen in Q1 2014 and has held it in 50 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.